Necessity of strengthening the current clinical regulatory for companion diagnostics: An institutional comparison of the FDA, EMA, and MFDS

Companion diagnostics (CDx), which is essential in precision medicine, is changing to a personalized treatment approach. CDx is a test that identifies patients who can benefit from a specific drug and those who experience side effects of drugs for safe and effective treatment. Conversely, when CDx h...

Descripción completa

Detalles Bibliográficos
Autores principales: Kang, Su Lim, Woo, Jae Hyun, Kim, Na Hyeon, Kwon, Ji Yean, Kim, Sung Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: American Society of Gene & Cell Therapy 2023
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474566/
https://www.ncbi.nlm.nih.gov/pubmed/37663648
http://dx.doi.org/10.1016/j.omtm.2023.08.008

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10474566/
https://www.ncbi.nlm.nih.gov/pubmed/37663648
http://dx.doi.org/10.1016/j.omtm.2023.08.008

Ejemplares similares